131 related articles for article (PubMed ID: 3510944)
1. Chemotherapy of advanced ovarian adenocarcinoma: a randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin.
Gynecol Oncol; 1986 Jan; 23(1):1-13. PubMed ID: 3510944
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.
Williams CJ; Mead GM; Macbeth FR; Thompson J; Whitehouse JM; MacDonald H; Harvey VJ; Slevin ML; Lister TA; Shepherd JH
J Clin Oncol; 1985 Nov; 3(11):1455-62. PubMed ID: 3903062
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma.
Barker GH; Wiltshaw E
Lancet; 1981 Apr; 1(8223):747-50. PubMed ID: 6110955
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.
Wiltshaw E; Evans B; Rustin G; Gilbey E; Baker J; Barker G
J Clin Oncol; 1986 May; 4(5):722-9. PubMed ID: 3517243
[TBL] [Abstract][Full Text] [Related]
5. Failure of second-look laparotomy to influence survival in epithelial ovarian cancer.
Luesley D; Lawton F; Blackledge G; Hilton C; Kelly K; Rollason T; Wade-Evans T; Jordan J; Fielding J; Latief T
Lancet; 1988 Sep; 2(8611):599-603. PubMed ID: 2900980
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival with advanced ovarian cancer: an analysis of 5-year survivors in the Australian trial comparing combination versus sequential chlorambucil and cisplatin therapy.
Tattersall MH; Swanson CE; Solomon HJ
Gynecol Oncol; 1992 Dec; 47(3):292-7. PubMed ID: 1473740
[TBL] [Abstract][Full Text] [Related]
7. Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum.
Bell DR; Woods RL; Levi JA; Fox RM; Tattersall MH
Aust N Z J Med; 1982 Jun; 12(3):245-9. PubMed ID: 7052040
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary report.
Piver MS; Malfetano J; Hempling RE; Baker TR; Driscoll DL
Gynecol Oncol; 1990 Dec; 39(3):249-52. PubMed ID: 2258065
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group Trial II.
Lawton F; Luesley D; Blackledge G; Hilton C; Kelly K; Latief T; Mould J; Spooner D; Rollason T; Wade-Evans T
Clin Oncol (R Coll Radiol); 1990 Jan; 2(1):4-9. PubMed ID: 2261388
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
Leonard RC; Smart GE; Livingstone JR; Cornbleet MA; Kerr GR; Fletcher S; Webb JN; Smyth JF
Cancer Chemother Pharmacol; 1989; 23(2):105-10. PubMed ID: 2491962
[TBL] [Abstract][Full Text] [Related]
13. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
[TBL] [Abstract][Full Text] [Related]
14. Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma.
Baker TR; Piver MS; Hempling RE
Cancer; 1994 Jul; 74(2):656-63. PubMed ID: 8033045
[TBL] [Abstract][Full Text] [Related]
15. Combined cyclophosphamide, adriamycin and cis-platinum in advanced ovarian cancer resistant to chlorambucil and cis-platinum.
Mann GJ; Malden LT; Solomon HJ; Tattersall MH
Gynecol Oncol; 1985 Jun; 21(2):215-9. PubMed ID: 3886497
[TBL] [Abstract][Full Text] [Related]
16. A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study.
Diéras V; Guastalla JP; Ferrero JM; Curé H; Weber B; Winckel P; Lortholary A; Mayer F; Paraiso D; Magherini E; Pujade-Lauraine E
Cancer Chemother Pharmacol; 2004 Jun; 53(6):489-95. PubMed ID: 14767617
[TBL] [Abstract][Full Text] [Related]
17. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report.
Piver MS; Malfetano J; Baker TR; Lele SB; Marchetti DL
Gynecol Oncol; 1989 Oct; 35(1):69-72. PubMed ID: 2792905
[TBL] [Abstract][Full Text] [Related]
19. The role of surgical reexploration following chemotherapy in ovarian cancer.
Solomon J
Aust N Z J Obstet Gynaecol; 1988 May; 28(2):121-6. PubMed ID: 3067699
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
Piver MS; Recio FO; Baker TR; Driscoll D
Cancer; 1994 Mar; 73(6):1693-8. PubMed ID: 7512437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
